Plant genome editing vector, method and application thereof
Patent Information
- Application Number
- CN202610221084.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2025-02-18
- Filing Date
- 2026-02-24
- Publication Date
- 2026-08-18
AI Technical Summary
[0008]目前,国内自主专利的Cas12i核酸内切酶数量较少,这在一定程度上阻碍了我国基因编辑作物育种的进程
本发明提供的一种植物基因组编辑载体及其方法和应用,为了提高Cas12类在玉米中的编辑效率,发明人从多方面对编辑载体结构进行优化,首先对CasWM核苷酸序列进行密码子和添加T5外切酶优化,提高了CasWM蛋白在玉米中的编辑效率;其次,优化crRNA的表达结构,使用U6复合启动子-tRNA-crRNA-HDV复合结构来提高crRNA的表达量,进而提高Cas蛋白的编辑效率,通过使用优化后的U6复合启动子表达crRNA,并在crRNA的上下游分别添加tRNA和HDV序列在提高crRNA的表达量的同时进而稳定crRNA的结构,使得CasWM蛋白的编辑效率进一步得到大大提升;另外本发明设计筛选了三种U6复合启动子,最终获得在植物中编辑效率极高的基因编辑载体。
Smart Images

Figure CN122588051A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of biotechnology, specifically to a plant genome editing vector, its method, and its applications. This patent claims priority to patent publication number CN120272501A. Background Technology
[0002] In many bacteria and most archaea, there exists a defense system against foreign DNA (such as bacteriophages) called the CRISPR / Cas (Clustered Regularly Interspaced Short Palindromic Repeats / CRISPR-associated Cas endonuclease) system (Bhaya et al., 2011). The CRISPR / Cas system comprises two basic components: the Cas protein, a nuclease, and guide RNA (gRNA). Under specific conditions, the gRNA forms a complex with the Cas protein, guiding the Cas protein to the target DNA through complementary base pairing. This allows the Cas protein to bind to and cleave the target double-stranded DNA, resulting in a double-strand break. Subsequently, the cell's DNA repair mechanisms repair the damaged double-stranded DNA, including non-homologous end joining (NHEJ) and homologous recombination repair (HDR) (Hsu et al., 2014).
[0003] Plant gene editing technology developed using the CRISPR / Cas system is a key technology in crop breeding. Researchers have used classic gene-editing nucleases such as Cas9 and Cpf1 as basic tools to develop and apply numerous downstream technologies, achieving a series of important results in the field of plant gene editing.
[0004] Based on the number and composition of Cas proteins involved in genome cleavage by nucleases, the CRISPR / Cas system is divided into class I (types I, III, and IV) and class II (types II, V, and VI) systems. In class II systems, the type II nuclease Cas9 contains an HNH nuclease domain inserted into the RuvC nuclease domain; these two domains work together to cleave double-stranded DNA three bases upstream of the PAM (5'-NGG-3') site, producing blunt ends. By introducing point mutations into the nuclease domain, nickase-Cas9 (nCas9) or dead-Cas9 (dCas9) can be generated for the development of base editors and gene expression regulators.
[0005] Unlike Cas9, V-type Cas12a has a single RuvC nuclease domain that cleaves double-stranded DNA by recognizing T-rich PAM sequences (5'-TTTN-3') to produce sticky ends, thereby expanding the range of available targets.
[0006] Over the past few years, Cas9 (type II) and Cas12a have been widely used for genome editing in various organisms, including microorganisms, animals, and plants. Due to the diversity of type V CRISPR / Cas systems, many recently reported novel Cas proteins are members of the type V endonuclease family. Among them, CRISPR / Cas12 shows great potential as a genome editing tool due to its relatively small size, simple crRNA, "TTN" PAM requirement, and pre-crRNA processing capability.
[0007] Cas12 is a single crRNA-guided effector that primarily cleaves the non-spacer complementary strand of the target DNA and, with lower efficiency, cleaves the spacer complementary strand, resulting in double-strand DNA breaks. Several members of the Cas12 family, including Cas12i1, Cas12i2, Cas12i3, Cas12i7, Cas12i10, Cas12i11, and Cas12i12, have demonstrated gene-editing activity in mammalian cells. In 2023, researchers identified Cas12i3, a member of the endonuclease family VI, to determine its application in plant genome editing. This protein recognizes PAMs of TTN, achieving an average editing efficiency of 36.31% at four endogenous rice sites (OsYSA, OsNAL, OsMIR396e, and OsPYL6). The engineered Cas12i3 (Cas-SF01) has an expanded PAM range, effectively recognizing PAMs of NTTN as well as atypical NATN and TTVN, with further improved editing efficiency, reaching up to 80% in rice.
[0008] Currently, the number of domestically patented Cas12i endonucleases is relatively small, which to some extent hinders the progress of gene-edited crop breeding in my country. Furthermore, most researchers focus on optimizing the amino acid sequence of the nuclease protein, resulting in relatively singular protein efficiency optimization strategies. Reports on efficiently achieving Cas12 protein-mediated gene editing in plants are currently very scarce, and the gene editing efficiency is also low. Summary of the Invention
[0009] To address at least one deficiency or improvement need in existing technologies, the inventors of this invention have combined multiple editing vector optimization strategies, including optimization of the nucleotide sequence of CasWM protein, optimization of crRNA expression structure, and promoter screening, to greatly improve the editing efficiency of CasWM protein. Ultimately, a novel gene editing vector with high editing efficiency for plant genomes was screened out. This novel editing tool further expands the plant Cas12 family gene editing tools and can be used to cultivate new plant varieties.
[0010] To achieve the above objectives, according to one aspect of the present invention, a codon-optimized nucleotide sequence encoding a CasWM protein is provided, wherein the nucleotide sequence is SEQ ID NO.1 or SEQ ID NO.2, preferably SEQ ID NO.2.
[0011] In another embodiment, the present invention provides a nucleic acid construct for editing a plant genome, the nucleic acid construct comprising: The first expression box for expressing the CasWM protein; The second expression cassette for sgRNA expression; And the third expression box expressing plant transformation selection markers; The first expression box includes the nucleotide sequence of claim 1 and the first promoter; the second expression box includes sgRNA and the second promoter.
[0012] In one embodiment, the second expression box includes elements of Formula I: P1-X1-L1-H1 (I); Where P1 is the second promoter sequence; X1 is the tRNA sequence; L1 is the crRNA sequence; H1 is the HDV sequence; and each "-" is an independent bond or nucleotide linking sequence.
[0013] Preferably, the second promoter comprises any one of the nucleotide sequences in SEQ ID NO.3 to SEQ ID NO.5.
[0014] Preferably, the second promoter has a structure of formula II: P2-X2-L2 (II); Wherein P2 is a 35S enhancer sequence; X2 is a CMYLCV sequence; L2 is any nucleotide sequence from SEQ ID NO.3 to SEQ ID NO.5, preferably the nucleotide sequence shown in SEQ ID NO.5.
[0015] In another embodiment, the first promoter initiates CasWM expression. In a preferred embodiment, when the plant is a monocotyledonous plant, the first expression cassette uses the maize ubiquitin gene promoter (ZmUBI) to initiate CasWM expression, adds NLS (nuclear signal peptide) to the C-terminus and N-terminus of CasWM, and uses the NOS terminator; when the plant is a dicotyledonous plant, the first expression cassette uses the 35S promoter to initiate CasWM expression, adds NLS (nuclear signal peptide) to the C-terminus and N-terminus of CasWM, and uses the NOS terminator.
[0016] In another embodiment, the third expression box includes P3-X3-L3 (III). P3 is the third promoter sequence; including but not limited to the 35S promoter, CMV promoter, CAG promoter, PGK promoter; X3 is a plant transformation screening marker, preferably a Bar screening marker; L3 is a polyA sequence; Furthermore, an expression vector is also provided, wherein the expression vector contains any of the nucleic acid constructs described above.
[0017] Furthermore, a host cell is also provided, wherein the cell contains the above-described expression vector, or its genome is integrated with any of the above-described nucleic acid constructs.
[0018] Furthermore, a kit for plant genome editing is also provided, comprising: the above-mentioned nucleic acid construct, or an expression vector containing said nucleic acid construct.
[0019] Furthermore, a plant breeding method is also provided, comprising the following steps: (i) Provide the plant or plant cell to be edited; (ii) The expression vector containing the nucleic acid construct of claim 3 is introduced into the plant or plant cell to be edited, thereby achieving the editing of the target gene of the plant or plant cell.
[0020] In another preferred embodiment, the plants include monocotyledons and dicotyledons.
[0021] In another preferred embodiment, the plant is selected from the group consisting of: rice, corn, soybean, tomato, tobacco, wheat, watermelon, cucumber, cotton, sorghum, Arabidopsis thaliana, barley, oats, millet, peanut, or combinations thereof.
[0022] In summary, compared with the prior art, the above-described technical solutions conceived by this invention can achieve the following beneficial effects: This invention provides a plant genome editing vector, its method, and its application. To improve the editing efficiency of Cas12-type genomes in maize, the inventors optimized the vector structure from multiple aspects. First, they optimized the CasWM nucleotide sequence by codon optimization and the addition of a T5 exonuclease, thereby improving the editing efficiency of CasWM protein in maize. Second, they optimized the expression structure of crRNA by using a U6 complex promoter-tRNA-crRNA-HDV complex structure to increase the expression level of crRNA, thus improving the editing efficiency of Cas protein. By expressing crRNA using the optimized U6 complex promoter and adding tRNA and HDV sequences upstream and downstream of crRNA, respectively, the expression level of crRNA is increased while the structure of crRNA is stabilized, further significantly improving the editing efficiency of CasWM protein. In addition, this invention designed and screened three U6 complex promoters, ultimately obtaining a gene editing vector with extremely high editing efficiency in plants.
[0023] This invention provides a plant genome editing vector, a method thereof, and an application of the plant genome editing vector. The optimized vector with the best editing effect is used to edit endogenous genes in plants, achieving efficient gene editing in both monocotyledonous and dicotyledonous plants. Attached Figure Description
[0024] Figure 1 This is a schematic diagram of the gene editing vector structure provided in an embodiment of the present invention; Figure 2 This is a schematic diagram of the three U6 composite promoter structures provided in an embodiment of the present invention; Figure 3 This is a diagram showing the results of gene editing using the three U6 complex promoters provided in this embodiment of the invention; Figure 4 This is a first-generation sequencing peak diagram of the gene editing vector provided in this embodiment of the invention, which is used to edit the target sites of three endogenous genes (ZmLAC1, ZmBGLU11 and ZmNL4) in maize. Detailed Implementation
[0025] To make the objectives, technical solutions, and advantages of this invention clearer, the invention will be further described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative and not intended to limit the invention. Furthermore, the technical features involved in the various embodiments of this invention described below can be combined with each other as long as they do not conflict with each other.
[0026] It should be noted that any aspects of this invention not described in detail are well known to those skilled in the art. Experimental methods in the following embodiments that do not specify specific conditions are generally performed under conventional conditions or as recommended by the manufacturer, and experimental steps are not described in detail.
[0027] As used in this article, the term "plant promoter" refers to a nucleic acid sequence that can initiate nucleic acid transcription in plant cells. A plant promoter can be derived from plants, microorganisms (such as bacteria or viruses), or animals, or it can be a synthetically produced or modified promoter.
[0028] As used herein, the term "CasWM protein" refers to a nuclease. In this invention, the CasWM protein belongs to the Cas12 protein family, and its amino acid sequence is shown in SEQ ID NO.3: The codon-optimized coding sequence of the CasWM protein obtained in this invention can significantly increase the expression level of the CasWM protein and also significantly improve the editing efficiency of the CasWM protein in plants.
[0029] As used herein, the term "plant" includes the whole plant, plant organs (such as leaves, stems, roots, etc.), seeds, and plant cells, as well as their progeny. There are no particular limitations on the types of plants that can be used in the methods of this invention, and generally include any type of higher plant that can be transformed, including monocots, dicots, and gymnosperms.
[0030] As used herein, the terms "expression cassette" or "expression frame" refer to a polynucleotide sequence containing the gene to be expressed and the sequence components required for expression. The components required for expression include a promoter and a polyadenylation signal sequence. Furthermore, the expression cassette or expression frame of the present invention may contain or not contain other sequences, including (but not limited to): enhancers, secretion signal peptide sequences, etc.
[0031] As used in this article, the term "sgRNA," also known as "guide RNA," is a single-stranded RNA with a 5' end that is complementary to the target DNA. The gRNA uses this complementary sequence to target Cas9 to a specific genomic site. Typically, in gene editing systems, there is a PAM sequence following (or preceding) the gRNA.
[0032] As used herein, “screening marker gene” refers to a gene used in the transgenic process to screen transgenic cells or transgenic animals. There are no particular limitations on the screening marker genes that can be used in this application, including various screening marker genes commonly used in the transgenic field. Representative examples include (but are not limited to): luciferin, or luciferase (such as firefly luciferase, kidney luciferase), green fluorescent protein, yellow fluorescent protein, red fluorescent protein, or combinations thereof.
[0033] As used in this article, "HDV sequence" refers to the ribonucleic acid (RNA) sequence of hepatitis D virus (HDV) present in plasmids. In this article, the nucleotide sequence of "HDV sequence" is: GGCCGGCATGGTCCCAGCCTCCTCGCTGGCGCCGGCTGGGCAACATGCTTCGGCATGGCGAATGGGAC.
[0034] As used in this article, "CMYLCV sequence" refers to the following sequence: GGCAGACATACTGTCCCACAAATGAAGATGGAATCTGTAAAAGAAAACGCGTGAAATAATGCGTCTGACAAAGGTTAGGTCGGCTGCCTTTAATCAATACCAAAGTGGTCCCTACCACGATGGAAAAACTGTGCAGTCGGTTTGGCTTTTTCTGACGAACAAATAAGATTCGTGGCCGACAGGTGGGGGTCCACCATGTGAAGGCATCTTCAGACTCCA ATAATGGAGCAATGACGTAAGGGCTTACGAAATAAGTAAGGGTAGTTTGGGAAATGTCCACTCACCCGTCAGTCTATAAATACTTAGCCCCTCCCTCATTGTTAAGGGAGCAAAATCTCAGAGAGATAGTCCTAGAGAGAGAAAGAGCAAGTAGCCTAGAAGTAGTCAAGGCGGCGAAGTATTCAGGCACGTGGCCAGGAAGAAGAAAAGCCAAGACGACGAAAACAGGTAAGAGCTAAGC It should be noted that in this invention, "second promoter" and "U6 composite promoter" are different ways of referring to the same structure, both referring to a promoter containing any one of the sequences in SEQ ID NO.3 to SEQ ID NO.5.
[0035] Figure 1 This is a schematic diagram of the structure of the gene editing vector pCas-WM01 provided by the present invention, as shown below. Figure 1 As shown, the gene editing vector pCas-WM01 provided by this invention includes: The first expression box for expressing the CasWM protein; The second expression cassette for sgRNA expression; And the third frame of expression for the maize transformation screening marker; The first expression box includes the nucleotide sequence of claim 1 and the first promoter; the second expression box includes sgRNA and the second promoter.
[0036] In a preferred embodiment, when the plant is a monocotyledonous plant, the first promoter in the first expression frame is the maize ubiquitin gene promoter (ZmUBI) promoter, and when the plant is a dicotyledonous plant, the first promoter in the first expression frame is the 35s promoter; the C-terminus and N-terminus of the CasWM are supplemented with NLS (nuclear signal peptide) sequences, and the NOS terminator is used.
[0037] The second expression box includes elements of the formula I structure: P1-X1-L1-H1 (I); Where P1 is the second promoter sequence; X1 is the tRNA sequence; L1 is the crRNA sequence; H1 is the HDV sequence; and each "-" is an independent bond or nucleotide linking sequence.
[0038] The second promoter is a component of Formula II: P2-X2-L2 (II); Wherein P2 is a 35S enhancer sequence; X2 is a CMYLCV sequence; L2 is a U6 promoter; the U6 promoter nucleotide sequence is any one of SEQ ID NO.3 to SEQ ID NO.5, preferably the nucleotide sequence shown in SEQ ID NO.5.
[0039] Example 1: Optimization design of the nucleotide sequence of the CasWM protein Because the Cas12 family has consistently shown poor efficiency in plant gene editing, the inventors considered optimizing the CasWM protein in maize from multiple perspectives to improve its editing efficiency. First, they optimized the nucleotide sequence codons based on the CasWM amino acid sequence. Since most gene expression frames in maize have high GC content, they designed several pairs of CasWM nucleotide sequences with different GC contents to compare gene editing efficiency. The inventors found significant differences in gene editing efficiency among CasWM nucleotide sequences with different GC contents. Finally, from numerous experiments, they screened out a high-GC version of the CasWM nucleotide sequence, named Caswm01, whose nucleotide sequence is shown in SEQ ID NO.1. Second, the inventors attempted to add a T5 exonuclease to the CasWM protein nucleotide sequence to further improve editing efficiency, naming it Caswm02, whose nucleotide sequence is shown in SEQ ID NO.2. To compare the gene editing effects of Caswm01 and Caswm02, the inventors designed sgRNAs and used Caswm01 and Caswm02 to edit the ZmLAC1 gene in maize, and conducted transient transformation experiments on maize protoplasts to verify the editing efficiency. We used the inbred line maize KN5585, bred by Weimi Biotechnology (Jiangsu) Co., Ltd., to prepare protoplasts. Methods for maize protoplast isolation and transformation can be found in the literature. [1] The results are shown in Table 1.
[0040] As can be seen from the results in Table 1, after codon optimization, Caswm01 and Caswm02 have a certain editing efficiency for maize genes. The addition of T5 exonuclease to Caswm02 significantly improved the gene editing efficiency. Compared with Caswm01, the editing efficiency of Caswm02 was about doubled, reaching 77.8%, indicating that the optimization strategy of CasWM nucleotide sequence in this embodiment effectively improved the editing efficiency.
[0041] Table 1 Results of Caswm01 and Caswm02 editing of the maize ZmLAC1 gene
[0042] Example 2 Optimization of CasWM protein crRNA expression structure Furthermore, based on the optimization results of Example 1, the inventors optimized the expression structure of the CasWM protein crRNA, the schematic diagram of which can be found in [reference needed]. Figure 2To increase the expression level of crRNA, this invention uses a complex structure of U6 complex promoter-tRNA-crRNA-HDV to express crRNA, thereby improving the editing efficiency of CasWM protein. By using an optimized U6 complex promoter to express crRNA and adding tRNA and HDV sequences upstream and downstream of crRNA, respectively, the expression level of crRNA is increased while the structure of crRNA is stabilized, thus greatly improving the editing efficiency of CasWM protein.
[0043] In one embodiment, the U6 composite promoter includes a U6 promoter, an upstream 35S enhancer, and a CNYLCV element. To test which U6 composite promoter had the best effect, the inventors conducted extensive screening and optimization of the U6 promoter, ultimately selecting AtU6, ZmU61, and ZmU62, whose nucleotide sequences are shown in SEQ ID NO.3~SEQ ID NO.5, respectively. This resulted in multiple versions of the U6 composite promoter, named U6 composite v0, U6 composite v1, and U6 composite v2, respectively, with their structural diagrams shown below. Figure 2 .
[0044] The inventors designed sgRNA based on the maize endogenous gene ZmLAC1 and constructed it into the pCas-WM01 vector. Expression was initiated using the three U6 composite promoters mentioned above, resulting in three gene-editing vectors: pCasWM+U6 composite v0, pCasWM+U6 composite v1, and pCasWM+U6 composite v2. These three gene-editing vectors were transiently transformed into maize cells via protoplast transformation. After 24 hours of culture, cellular DNA was extracted and genotyping was performed. Protoplasts were prepared using the inbred line maize KN5585 bred by Weimi Biotechnology (Jiangsu) Co., Ltd. Methods for maize protoplast isolation and transformation can be found in the literature. [1] .
[0045] Test results as follows Figure 3 As shown, all three gene editing vectors have certain gene editing effects, among which the U6composite v2 promoter exhibits the best editing efficiency, exceeding 90%.
[0046] Example 3: Testing the effect of the optimized gene editing vector on gene editing in monocotyledonous plants. 3.1 Effects of editing different endogenous genes in maize Furthermore, based on the results of the crRNA expression structure optimization experiment in Example 2, we used the pCasWM+U6composite v2 gene editing vector to test the editing effect on three endogenous gene targets in maize (ZmLAC1, ZmBGLU11 and ZmNL4).
[0047] First, sgRNAs were designed for ZmLAC1, ZmBGLU11, and ZmNL4, respectively, and constructed into the pCasWM+U6 compositev2 gene editing vector. The vector was then used for stable genetic transformation of maize, resulting in 56 regenerated plants. Genotyping was performed on each T0 plant using first-generation sequencing. The results are shown in Table 2. The pCasWM+U6 composite v2 gene editing vector achieved high-efficiency editing in all three maize genes, with efficiencies ranging from 93.7% to 97.5%, reaching a maximum of 97.5%. This indicates that the optimized gene editing vector has excellent editing capabilities. Figure 4 This is a first-generation sequencing peak diagram of the three gene-editing vectors used in this embodiment to edit the target sites of three endogenous maize genes (ZmLAC1, ZmBGLU11, and ZmNL4). Figure 4 As can be seen from the first-generation sequencing peak diagram of the target site, at the ZmLAC1 gene site, the pCasWM+U6 composite v2 editing vector achieved homozygous deletion of the fragment ( Figure 4 A), at ZmBGLU11 and ZmNL4 sites ( Figure 4 B Figure 4 (c) The pCasWM+U6 compositev2 vector achieved heterozygous large fragment deletion. In summary, the pCasWM+U6 composite v2 gene editing vector enables efficient editing in maize, with most edits involving base deletions.
[0048] Table 2. Results of gene editing using the pCasWM+U6 composite v2 gene editing vector in maize.
[0049] 3.2 Effects of endogenous gene editing in rice and wheat Furthermore, we selected rice and wheat from monocotyledonous plants to further test the editing effect of the pCasWM+U6composite v2 gene editing vector pair. In rice, we selected the endogenous sange genes Os06g0133000, Os08g0509600, and Os03g0407400 as target sites and tested their editing efficiency. The results are shown in Table 3. The pCasWM+U6 composite v2 gene editing vector of this invention achieved high-efficiency editing in all three rice genes, with efficiencies ranging from 44.5% to 100%, and a maximum of 100% editing.
[0050] Table 3. Editing results of pCasWM+U6 composite v2 gene editing vector in rice.
[0051] We selected the endogenous gene TaFT-D in wheat and designed two target sites to test its editing efficiency. The results are shown in Table 4. Gene editing was also achieved at the two target sites in wheat, with the highest editing efficiency reaching 58.8%.
[0052] Table 4. Editing results of pCasWM+U6 composite v2 gene editing vector in wheat.
[0053] Example 4: Effect of the gene editing vector of the present invention on gene editing in dicotyledonous plants. Furthermore, this embodiment tested the gene editing effect of the gene editing vector of the present invention on dicotyledonous plants. Several dicotyledonous plants, including soybean, watermelon, cucumber, and cotton, were selected. In dicotyledonous plants, we designed two promoters, ZmU62 (sequence shown in SEQ ID NO.5) and U6 composite v2, targeting the second expression cassette of sgRNA. These promoters were constructed into the pCas-WM01 vector to obtain two gene editing vectors, pCasWM+U6 and pCasWM+U6 composite v2, which were used to drive the expression of sgRNA in dicotyledonous plants. The editing effects of gene editing vectors with the ZmU62 promoter alone and those with the composite U6 composite v2 promoter were compared.
[0054] The results are shown in Tables 5 to 7. The gene editing vectors constructed in this invention also achieved high-efficiency editing in dicotyledonous plants, and the gene editing vectors constructed with promoters having composite structures generally had higher editing efficiency than those constructed with promoters without composite structures.
[0055] Table 5. Gene editing effect of the gene editing vector of the present invention in soybean.
[0056] Table 6. Gene editing effect of the gene editing vector of the present invention in watermelon.
[0057] Table 7. Gene editing effect of the gene editing vector of the present invention in cucumber.
[0058] Table 8 Gene editing effect of the gene editing vector of the present invention in cotton.
[0059] In summary, this invention first optimizes the amino acid codons of CasWM with high GC and adds a T5 exonuclease, resulting in an optimized CasWM protein nucleotide sequence that enables plant genome editing. Secondly, it optimizes the expression structure of the CasWM protein crRNA by using a U6 complex promoter-tRNA-crRNA-HDV complex structure to express crRNA, thereby improving the editing efficiency of the CasWM protein. By using the optimized U6 complex promoter to express crRNA and adding tRNA and HDV sequences upstream and downstream of the crRNA, respectively, the expression level of crRNA is increased while its structure is stabilized, thus significantly improving the editing efficiency of the CasWM protein.
[0060] The final part of the U6 complex promoter sequence is the U6 promoter itself. Experiments have shown that AtU6 is not the optimal choice in maize. The inventors innovatively discovered two new U6 promoters, ZmU61 and ZmU62. Transient experiments showed that the ZmU62 version of the U6 complex promoter exhibited the best editing effect. Furthermore, the results demonstrate that the valence-changing effect of the U6 promoter with the complex structure is significantly higher than that of the promoter without the complex structure. This indicates that our optimization strategy is feasible and effective. In stable genetically transformed plants, the optimized editing vector achieved efficient editing in multiple monocotyledonous and dicotyledonous plants. Our novel editing tool further expands the plant Cas12 family gene editing tools, contributing to the breeding of new plant varieties.
[0061] Although the present invention has been described in detail above with general descriptions and specific embodiments, modifications or improvements can be made to it, which will be obvious to those skilled in the art. Therefore, all such modifications or improvements made without departing from the spirit of the present invention fall within the scope of protection claimed by the present invention.
[0062] Those skilled in the art will readily understand that the above description is merely a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, and improvements made within the spirit and principles of the present invention should be included within the scope of protection of the present invention.
[0063] References: [1] Tu, X., et al., Reconstructing the maize leaf regulatory network using ChIP-seq data of 104 transcription factors. Nat Commun, 2020.11(1): p. 5089. SEQ ID NO.1 SEQ ID NO.2 SEQ ID NO.3 ATGCCGTTCTGGTGGGCCCGCAGAAGAAAGCCATGGTACGGGCGCAGGTGGAACCGGAGGAGGTTTCAAACCCGTAGGCGCAGAAGGCGCAGAAGAAGATTTCCACGCAGAAGAACTAGAAGAACTTATCGCCGCCGCGGAAGAAAAAGAAAATACAAGGTAAGAAAAAAGAAAAAAAAGATCACCATACAACAATGGCAACCAGACTCTATTAGAAAATGCCACATAAAAGGACATGGAATTTTAGTACTAGGAGCAGAAGGAACTCAAATGAACTGTTTTACATGTCAAAAACTTAAATATGTACCTCCAAAAGTACCATATGGAGGAGGATTTGGAGTGGAAAAACACACCTTAAAACTATTATATGAAGAATATCAGTTTAAAAATAACATATGGACTGCTACTAACATACACAAAGACTTATGTAGATACCTATATGTTAGATTTACCATGTTTAGAGCACCTGAAACAGACTTTATTGTTAGCTATGATAGATCTCCTCCTTTTGAAATTAATCAATTTACATTTCCAAGTACACACCCACAACAAATGTTACTAGATAAACATAAAAAAGTTATTTTTAGCCTTGCTAGCAAACCAAATGGAAAATATAAAGTTAAATTCCTAGTAAAACCTCCTAGACAAATGATAACCAAATGGTTTTTCACCAAAGAATTTTCAAAATACCCATTACTACTGCTAAAAGGAACAGCAGCTAACTTTAGATATAGCTACCTCACAGCAAAAAACCAAAACTTACTGGTAAACATTTACTCTCTTAATATTAAAAATTTTTACATAAATTCTAATTGGGGTAAAAATGTTACAGGCACACATGGATACCAACCATACACAAACATTCAAAAAGGATTACTATACTCTACACTATTAAAAAATGGTGCGGAACAAAAACATAACATGCCAGATGCAGCATTTAATACTTATGACGGTAGTGTTAACTATGATA CAGGCTGGTTTATGCCTGCATTTTTACAAG CATATAAAAT ATATACCAAGGAAGGATCACCAACAGGAACAAACCAATTAATATATGCCAGATATAACCCAATGAAAGACAATGGCATAGGAAACAAAATTTATTTAGCTAGTATACTAGCAGACCATTGGGGACCACCACAACATGACAAACAACTACTACTAGAAAAC TTTCCACTAT GGCTAGGCCTATGGGGATACCTAGATTTTATAAGCAATTAAACCAATAGACTATATGAAATCCAGTGTTGTAGTACTAGATGCCATATTGTTATCCAAGTAGGAGTTGTAAAGCATATGTACCCATTGACTATGACTACATTTTAGGCAAAAAACTGGGAACACACTAACTAACAGCAAAGTAGATGGTATCCAACTGACTGACTGGAGTT CAACTTAAAACCTTAAATGCCATAGCAGAAACAGGTCCCTTTGTGCCTAAATACTCAGACAGCACAAACAGCACATGGGAACTAAAATATCACTATTTTTGCTTTAAGTGGGGTGGACCAGCACTTCCTGAACAAGATGTCAAAAATCCAACCTCCCCACCTATGATGTTCCCAGCCAGCCAACCATACAT ATACAAATCAGGAACCCAGAAACAAGCCAGAAACAATATTCCATCCCTGGGACTACAGGGGGAATTATTTAAAAAAGAGCTTAAAAGAATGTGCCAGTACCTCGAAACTGATACAGAATTTGACTATTCTACAGAAAGCTCCAAAAAAAGAATTCCAGAATCGGAGCCGCTCCGACCCAGAATCCCAGAATCGGACTGAGCCAGGAATCCGAATTCGATACAGAATTCGACTATTCTACAGAAAGCTCCAAAAAGAAAGATCCAGAATCGGAGCCGCTCCAACCAGGAATTATTTAAAAAGAGCTTAAAAAGAATGTGCCAGTACCTCGAAACTGATACAGAATTTGACTATTCTACAGAAAGCTCCAAAAAAAGAATCCGA AGAAAAAACACAAGAAGCGAAGGAATGTCTCCTCCAGTCTCTGCAAAGAAAATATCTACCAAGAACAAGAAACACTGGAGCAGCTCATCCACCAGCAGCAGCAGCAACAGCTCAAGTACAACCTCGTCAAACTCCTCATAGATTTGAAACAAACAGAGAATGCTTCAACTTAGCAAGCTAGCCT AGAIN SEQ ID NO.4 GCTGTTTTTGTTAGCCCCATCGAATCCTTGACATAATGATCCCGCTTAAATAAGCAACCTCGCTTGTATAGTTCCTTGTGCTCTAACACACGATGATGATAAGTCGTAAAATAGTGGTGTCCAAAGAATTTCCAGGCCCAGTTGTAAAAGCTAAAATGCTATTCGAATTTCTACTAGCAGTAAGTCGTGTTTAGAAATTATTTTTTTATATACCTTTTTTCCTTCTATGTACAGTAGGACACAGTGTCAGCGCCGCGTTGACGGAGAATATTTGCAAAAAAGTAAAAGAGAAAGTCATAGCGGCGTATGTGCCAAAAACTTCGTCACAGAGAGGGCCATAAGAAACATGGCCCACGGCCCAATACGAAGCACCGCGACGAAGCCCAAACAGCAGTCCGTAGGTGGAGCAAAGCGCTGGGTAATACGCAAACGTTTTGTCCCACCTTGACTAATCACAAGAGTGGAGCGTACCTTATAAACCGAGCCGCAAGCACCGAATT SEQ ID NO.5 CTAATTGGCCCTTACAAAATAGCTAGACGTGCAGGTGGCTGGATGTGCGCTCCCTGAATATCAACTTGTGTCTCCTCCGATTCAGTCCGCAGATGAAACTTGGTAATAACTGCAGCTGATCCGTCGTCATTCATGCTATGCAGGGGATTCGATCTTCAGCATGTGCAGTGCAGGCAACAACAATCTACGTTGTCTGGGCTTGCGATAGGTACACGACCACGAGGGAAGGCAACGCGTGATGTATGGGCCGCGCCTAAGCATCCAGCCCACGCGGGCGTGCGCGTCGTCGCTACGGCTTGCGGGGGAAGGGATCAAGGGACGAACCGAGAACTAGTACCAGACCGGCCAGCGAGCATTGCAGACACCGGCTTATAAGTTCAGCTGCGACCACCGCTCC
Claims
1. A codon-optimized nucleotide sequence encoding a CasWM protein, characterized in that, The nucleotide sequence is SEQ ID NO.1 or SEQ ID NO.2, preferably SEQ ID NO.
2.
2. A nucleic acid construct for editing plant genomes, characterized in that, The nucleic acid constructs include: The first expression box for expressing the CasWM protein; The second expression cassette for sgRNA; And the third expression box expressing plant transformation selection markers; The first expression box includes the nucleotide sequence of claim 1 and the first promoter; the second expression box includes sgRNA and the second promoter.
3. The nucleic acid construct for editing plant genomes as described in claim 2, characterized in that, The second expression box includes elements of the formula (I): P1-X1-L1-H1 (I) Where P1 is the second promoter sequence; X1 is the tRNA sequence; L1 is the crRNA sequence; H1 is the HDV sequence; and each "-" is an independent bond or nucleotide linking sequence.
4. The nucleic acid construct for editing plant genomes as described in claim 2 or 3, characterized in that, The second promoter includes any one of the nucleotide sequences in SEQ ID NO.3 to SEQ ID NO.
5.
5. The nucleic acid construct for editing plant genomes as described in claim 4, characterized in that, The second promoter has the structure of formula (II): P2-X2-L2 (II); Wherein P2 is a 35S enhancer sequence; X2 is a CMYLCV sequence; L2 is any nucleotide sequence from SEQ ID NO.3 to SEQ ID NO.5, preferably the nucleotide sequence shown in SEQ ID NO.
5.
6. An expression carrier, characterized in that, The expression vector contains the nucleic acid construct as described in any one of claims 2 to 5.
7. A host cell, characterized in that, The cell contains an expression vector as described in claim 6, or its genome is integrated with a nucleic acid construct as described in any one of claims 2 to 5.
8. A kit for plant genome editing, characterized in that, include: The nucleic acid constructs according to claims 2 to 5, or expression vectors containing the nucleic acid constructs.
9. A plant breeding method, characterized in that, Includes the following steps: (i) Provide the plant or plant cell to be edited; (ii) The expression vector containing the nucleic acid construct of claim 3 is introduced into the plant or plant cell to be edited, thereby achieving the editing of the target gene of the plant or plant cell.
10. The application of the nucleotide sequence of claim 1, the nucleic acid construct of any one of claims 2 to 5, the expression vector of claim 5, the host cell of claim 7, the kit of claim 8, and the breeding method of claim 9 in plant breeding.
